Trial intelligence / Profile preview

Dexmedetomidine Infusion Without Loading Dose in Craniotomy

NCT04607525Phase 4Completed

Sponsor
Ain Shams University
Start
Nov 2020
Primary completion
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of dexmedetomidine in hemodynamic instability (2 arms), sponsored by Ain Shams University. Primary endpoints: Mean Arterial Blood Pressure, Heart Rate and 1 more. Started Nov 2020; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

hemodynamic instability

Beyond the preview

Go deeper on NCT04607525.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04607525.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call